BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2987425)

  • 1. Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment.
    Gaffney CC; Sloane JP; Bradley NJ; Bloom HJ
    J Neurooncol; 1985; 3(1):23-33. PubMed ID: 2987425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation in medulloblastomas and other primitive neuroectodermal tumours.
    Sime PJ; Gordon A; Hooper ML; Bell JE
    Br J Neurosurg; 1989; 3(1):89-100. PubMed ID: 2789717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
    Herpers MJ; Budka H
    Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primitive neuroectodermal (neuroepithelial) tumour of soft tissue of the neck in a child: demonstration of neuronal and neuroglial differentiation.
    Shuangshoti S
    Histopathology; 1986 Jun; 10(6):651-8. PubMed ID: 2426177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primitive neuroectodermal tumors of the cerebrum: a histological and immunohistochemical study of 10 cases.
    Grant JW; Steart PV; Gallagher PJ
    Clin Neuropathol; 1988; 7(5):228-33. PubMed ID: 2850125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinicopathological analysis of primitive neuroectodermal tumors of the CNS].
    Zhang Q; Su X; Liang S
    Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):282-5. PubMed ID: 11244998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children.
    Schindler E; Gullotta F
    Virchows Arch A Pathol Anat Histopathol; 1983; 398(3):263-75. PubMed ID: 6298997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.
    Visée S; Soltner C; Rialland X; Machet MC; Loussouarn D; Milinkevitch S; Pasco-Papon A; Mercier P; Rousselet MC
    Histopathology; 2005 Apr; 46(4):403-12. PubMed ID: 15810952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glial fibrillary acidic protein and neurofilament protein in medulloblastoma].
    Tohyama T; Kubo O; Katahira M; Sakairi M; Tajika T; Tajika Y; Kitamura K
    No Shinkei Geka; 1988 Oct; 16(11):1243-50. PubMed ID: 3145467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
    Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
    Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors.
    Tajima Y; Molina RP; Rorke LB; Kaplan DR; Radeke M; Feinstein SC; Lee VM; Trojanowski JQ
    Acta Neuropathol; 1998 Apr; 95(4):325-32. PubMed ID: 9560008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of an oligodendroglioma into a primitive neuroectodermal tumour.
    MacKenzie JM; Franks AJ; van Hille PT; Cameron MM
    Neuropathol Appl Neurobiol; 1988; 14(1):71-9. PubMed ID: 2836745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vimentin and glial fibrillary acidic protein in human brain tumors.
    Yung WK; Luna M; Borit A
    J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma.
    Packer RJ; Sutton LN; D'Angio G; Evans AE; Schut L
    Pediatr Neurosci; 1985-1986; 12(4-5):272-82. PubMed ID: 3039477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
    Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
    Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic Characterization of Germ Cell Tumor-Derived Primitive Neuroectodermal Tumors: Evidence for Frequent Neuronal and/or Glial Differentiation.
    Magers MJ; Perrino CM; Ulbright TM; Idrees MT
    Arch Pathol Lab Med; 2021 Aug; 145(8):953-959. PubMed ID: 33290506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanotic primitive neuroectodermal (neuroepithelial) tumor of medulla.
    Shuangshoti S
    J Surg Oncol; 1986 May; 32(1):37-42. PubMed ID: 3014224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
    Woodburn RT; Azzarelli B; Montebello JF; Goss IE
    J Neurooncol; 2001 Mar; 52(1):57-62. PubMed ID: 11451203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastoma: histological evaluation and prognosis. A clinical, immunohistochemical and electron microscopic study.
    Szymas J; Biczysko W; Gabryel P; Morkowski S
    Childs Nerv Syst; 1987; 3(2):74-80. PubMed ID: 3304626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.